Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.02 USD | -0.86% |
|
-0.59% | -10.23% |
06-05 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
05-30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.23% | 1.79B | |
+2.87% | 94.22B | |
-3.42% | 37.76B | |
-13.14% | 32.5B | |
+72.50% | 27.75B | |
-12.70% | 16.13B | |
-0.58% | 14.19B | |
-12.95% | 11.42B | |
+190.36% | 11.06B | |
-54.07% | 9.09B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Catalyst Pharmaceuticals Partner Submits New Drug Application for Neuromuscular Disorder Treatment in Japan